HH Biotechnology Holdings Co (HH Biotechnology Holdings Co) EV-to-EBITDA : 0.00 (As of Jun. 23, 2024)

HH Biotechnology Holdings Co EV-to-EBITDA Chart

HH Biotechnology Holdings Co Annual Data
	Trend	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15
EV-to-EBITDA		Get a 7-Day Free Trial					4.88	5.51	4.85	15.28	6.02

HH Biotechnology Holdings Co Quarterly Data
	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16
EV-to-EBITDA	Get a 7-Day Free Trial															10.65	6.02	4.97	7.56	5.57

Competitive Comparison of HH Biotechnology Holdings Co's EV-to-EBITDA

For the Real Estate Services subindustry, HH Biotechnology Holdings Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HH Biotechnology Holdings Co's EV-to-EBITDA Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, HH Biotechnology Holdings Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where HH Biotechnology Holdings Co's EV-to-EBITDA falls into.

HH Biotechnology Holdings Co EV-to-EBITDA Calculation

HH Biotechnology Holdings Co's EV-to-EBITDA for today is calculated as:

HH Biotechnology Holdings Co's current Enterprise Value is $0.00 Mil.
HH Biotechnology Holdings Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HH Biotechnology Holdings Co  (OTCPK:HHBT) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

HH Biotechnology Holdings Co's PE Ratio for today is calculated as:

HH Biotechnology Holdings Co's share price for today is $0.0003.
HH Biotechnology Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.190.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

HH Biotechnology Holdings Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of HH Biotechnology Holdings Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

HH Biotechnology Holdings Co (HH Biotechnology Holdings Co) Business Description